We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Scientists Appeal Decision In Eli Lilly Patent Suit

Law360 (May 10, 2006, 12:00 AM EDT) -- Doctors that allege they co-discovered a gene used in Eli Lilly’s high-earning drug Xigris, appealed last Friday a decision by a judge in support of the giant pharmaceutical company.

Gerald Crabtree and his former research colleague Jorge Plutzky contend that they cloned a Protein C gene, and that Lilly that did not include their names when it filed a patent for the gene in order to avoid paying royalties.

Xigris, which is used to combat the blood infection sepsis, earned $215 million for Lilly last year....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.